These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 20701405)
41. Inherited, non-spherocytic haemolysis due to deficiency of glucose-6-phosphate dehydrogenase. Ronquist G; Theodorsson E Scand J Clin Lab Invest; 2007; 67(1):105-11. PubMed ID: 17365988 [TBL] [Abstract][Full Text] [Related]
42. Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies. Uthman OA; Graves PM; Saunders R; Gelband H; Richardson M; Garner P Malar J; 2017 Aug; 16(1):346. PubMed ID: 28830424 [TBL] [Abstract][Full Text] [Related]
43. Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose-6-phosphate dehydrogenase deficiency. Cheah CY; Lew TE; Seymour JF; Burbury K Acta Haematol; 2013; 130(4):254-9. PubMed ID: 23860572 [TBL] [Abstract][Full Text] [Related]
47. The haemolytic effect of various regimens of primaquine with chloroquine in American Negroes with G6PD deficiency and the lack of an effect of various antimalarial suppressive agents on erythrocyte metabolism. Brewer GJ; Zarafonetis CJ Bull World Health Organ; 1967; 36(2):303-8. PubMed ID: 4864652 [TBL] [Abstract][Full Text] [Related]
48. Acute haemolytic crisis due to concomitant presence of infection and possible altered acetaminophen catabolism in a Philipino child carrying the G6PD-Vanua Lava mutation. Minucci A; De Luca D; Torti E; Concolino P; Maurizi P; Giardina B; Zuppi C; Capoluongo E Ann Clin Biochem; 2011 May; 48(Pt 3):282-5. PubMed ID: 21441392 [TBL] [Abstract][Full Text] [Related]
49. Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency. Kheng S; Muth S; Taylor WR; Tops N; Kosal K; Sothea K; Souy P; Kim S; Char CM; Vanna C; Ly P; Ringwald P; Khieu V; Kerleguer A; Tor P; Baird JK; Bjorge S; Menard D; Christophel E BMC Med; 2015 Aug; 13():203. PubMed ID: 26303162 [TBL] [Abstract][Full Text] [Related]
50. A hemolysis trigger in glucose-6-phosphate dehydrogenase enzyme deficiency. Vicia sativa (Vetch). Bicakci Z Saudi Med J; 2009 Feb; 30(2):292-4. PubMed ID: 19198723 [TBL] [Abstract][Full Text] [Related]
51. The effect of the coinheritance of Glucose-6-phosphate dehydrogenase deficiency on the severity of sickle cell disease. Fasola FA; Fowodu FO; Shokunbi WA; Kotila TR Niger Postgrad Med J; 2019; 26(2):118-122. PubMed ID: 31187752 [TBL] [Abstract][Full Text] [Related]
52. G6PD deficiency: global distribution, genetic variants and primaquine therapy. Howes RE; Battle KE; Satyagraha AW; Baird JK; Hay SI Adv Parasitol; 2013; 81():133-201. PubMed ID: 23384623 [TBL] [Abstract][Full Text] [Related]
53. Tafenoquine and G6PD: a primer for clinicians. Chu CS; Freedman DO J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30941413 [TBL] [Abstract][Full Text] [Related]
54. The reality of using primaquine. Burgoine KL; Bancone G; Nosten F Malar J; 2010 Dec; 9():376. PubMed ID: 21184691 [TBL] [Abstract][Full Text] [Related]
55. Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka. Gunawardena S; Kapilananda GM; Samarakoon D; Maddevithana S; Wijesundera S; Goonaratne LV; Karunaweera ND PLoS One; 2017; 12(2):e0171208. PubMed ID: 28152025 [TBL] [Abstract][Full Text] [Related]